Fang-Fang Yin

Prof. Dr. Fang-Fang Yin

Department of Radiation Oncology, Duke University, Durham, NC 27708, USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in International Journal of Radiation Oncology, Biology, Physics
Verified
Journal Article
Closed access
JKJohn P. Kirkpatrick
John P. Kirkpatrick
ZWZhiheng Wang
Zhiheng Wang
JSJohn H. Sampson
John H. Sampson
FMFrances McSherry
Frances McSherry
JHJames E. Herndon
James E. Herndon
Fang-Fang YinFang-Fang Yin
Fang-Fang Yin

1 November 2014 in International Journal of Radiation Oncology, Biology, Physics
Verified
Journal Article
Closed access
JYJuan Yang
Juan Yang
JCJing Cai
Jing Cai
HWHongjun Wang
Hongjun Wang
ZCZheng Chang
Zheng Chang
BCBrian G. Czito
Brian G. Czito
Fang-Fang YinFang-Fang Yin
Fang-Fang Yin

21 January 2009 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
JWJackie Wu
Jackie Wu
ZWZhiheng Wang
Zhiheng Wang
JKJohn P Kirkpatrick
John P Kirkpatrick
ZCZheng Chang
Zheng Chang
JMJeffrey J Meyer
Jeffrey J Meyer
Fang-Fang YinFang-Fang Yin
Fang-Fang Yin
This study evaluated the dosimetric impact of various treatment techniques as well as collimator leaf width (2.5 vs 5 mm) for three groups of tumors – spine tumors, brain tumors abutting the brainstem, and liver tumors. These lesions often present challenges in maximizing dose to target volumes without exceeding critical organ tolerance. Specifically, this study evaluated the dosimetric benefits of various techniques and collimator leaf sizes as a function of lesion size and shape. Fifteen cases (5 for each site) were studied retrospectively. All lesions either abutted or were an integral part of critical structures (brainstem, liver or spinal cord). For brain and liver lesions, treatment plans using a 3D-conformal static technique (3D), dynamic conformal arcs (DARC) or intensity modulation (IMRT) were designed with a conventional linear accelerator with standard 5 mm leaf width multi-leaf collimator, and a linear accelerator dedicated for radiosurgery and hypofractionated therapy with a 2.5 mm leaf width collimator. For the concave spine lesions, intensity modulation was required to provide adequate conformality; hence, only IMRT plans were evaluated using either the standard or small leaf-width collimators. A total of 70 treatment plans were generated and each plan was individually optimized according to the technique employed. The Generalized Estimating Equation (GEE) was used to separate the impact of treatment technique from the MLC system on plan outcome, and t-tests were performed to evaluate statistical differences in target coverage and organ sparing between plans. The lesions ranged in size from 2.6 to 12.5 cc, 17.5 to 153 cc, and 20.9 to 87.7 cc for the brain, liver, and spine groups, respectively. As a group, brain lesions were smaller than spine and liver lesions. While brain and liver lesions were primarily ellipsoidal, spine lesions were more complex in shape, as they were all concave. Therefore, the brain and the liver groups were compared for volume effect, and the liver and spine groups were compared for shape. For the brain and liver groups, both the radiosurgery MLC and the IMRT technique contributed to the dose sparing of organs-at-risk(OARs), as dose in the high-dose regions of these OARs was reduced up to 15%, compared to the non-IMRT techniques employing a 5 mm leaf-width collimator. Also, the dose reduction contributed by the fine leaf-width MLC decreased, as dose savings at all levels diminished from 4 – 11% for the brain group to 1 – 5% for the liver group, as the target structures decreased in volume. The fine leaf-width collimator significantly improved spinal cord sparing, with dose reductions of 14 – 19% in high to middle dose regions, compared to the 5 mm leaf width collimator. The fine leaf-width MLC in combination with the IMRT technique can yield dosimetric benefits in radiosurgery and hypofractionated radiotherapy. Treatment of small lesions in cases involving complex target/OAR geometry will especially benefit from use of a fine leaf-width MLC and the use of IMRT.

5 October 2018 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
WSWenzheng Sun
Wenzheng Sun
MJMingyan Jiang
Mingyan Jiang
JDJun Dang
Jun Dang
PCPanchun Chang
Panchun Chang
Fang-Fang YinFang-Fang Yin
Fang-Fang Yin
To investigate the effect of machine learning methods on predicting the Overall Survival (OS) for non-small cell lung cancer based on radiomics features analysis. A total of 339 radiomic features were extracted from the segmented tumor volumes of pretreatment computed tomography (CT) images. These radiomic features quantify the tumor phenotypic characteristics on the medical images using tumor shape and size, the intensity statistics and the textures. The performance of 5 feature selection methods and 8 machine learning methods were investigated for OS prediction. The predicted performance was evaluated with concordance index between predicted and true OS for the non-small cell lung cancer patients. The survival curves were evaluated by the Kaplan-Meier algorithm and compared by the log-rank tests. The gradient boosting linear models based on Cox’s partial likelihood method using the concordance index feature selection method obtained the best performance (Concordance Index: 0.68, 95% Confidence Interval: 0.62~ 0.74). The preliminary results demonstrated that certain machine learning and radiomics analysis method could predict OS of non-small cell lung cancer accuracy.

1 May 2016 in Practical Radiation Oncology
Verified
Journal Article
Closed access
CSCarl Stanhope
Carl Stanhope
ZCZheng Chang
Zheng Chang
ZWZhiheng Wang
Zhiheng Wang
Fang-Fang YinFang-Fang Yin
Fang-Fang Yin
GKGrace Kim
Grace Kim
JAJustus Adamson
Justus Adamson

13 December 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YCYushi Chang
Yushi Chang
KLKyle Lafata
Kyle Lafata
WSWenzheng Sun
Wenzheng Sun
CWChunhao Wang
Chunhao Wang
ZCZheng Chang
Zheng Chang
Fang-Fang YinFang-Fang Yin
Fang-Fang Yin
This study aimed to investigate the effectiveness of using delta-radiomics to predict overall survival (OS) for patients with recurrent malignant gliomas treated by concurrent stereotactic radiosurgery and bevacizumab, and to investigate the effectiveness of machine learning methods for delta-radiomics feature selection and building classification models. The pre-treatment, one-week post-treatment, and two-month post-treatment T1 and T2 fluid-attenuated inversion recovery (FLAIR) MRI were acquired. 61 radiomic features (intensity histogram-based, morphological, and texture features) were extracted from the gross tumor volume in each image. Delta-radiomics were calculated between the pre-treatment and post-treatment features. Univariate Cox regression and 3 multivariate machine learning methods (L1-regularized logistic regression [L1-LR], random forest [RF] or neural networks [NN]) were used to select a reduced number of features, and 7 machine learning methods (L1-LR, L2-LR, RF, NN, kernel support vector machine [KSVM], linear support vector machine [LSVM], or naïve bayes [NB]) was used to build classification models for predicting OS. The performances of the total 21 model combinations built based on single-time-point radiomics (pre-treatment, one-week post-treatment, and two-month post-treatment) and delta-radiomics were evaluated by the area under the receiver operating characteristic curve (AUC). For a small cohort of 12 patients, delta-radiomics resulted in significantly higher AUC than pre-treatment radiomics (p-value<0.01). One-week/two-month delta-features resulted in significantly higher AUC (p-value<0.01) than the one-week/two-month post-treatment features, respectively. 18/21 model combinations were with higher AUC from one-week delta-features than two-month delta-features. With one-week delta-features, RF feature selector + KSVM classifier and RF feature selector + NN classifier showed the highest AUC of 0.889. The results indicated that delta-features could potentially provide better treatment assessment than single-time-point features. The treatment assessment is substantially affected by the time point for computing the delta-features and the combination of machine learning methods for feature selection and classification.